Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials
Crossref DOI link: https://doi.org/10.1186/s12894-016-0148-4
Published Online: 2016-06-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakayama, Masahiko
Kobayashi, Hisanori
Takahara, Tomihiro
Oyama, Ryo
Imanaka, Keiichiro
Yoshizawa, Kazutake
Funding for this research was provided by:
Janssen Pharmaceuticals
License valid from 2016-06-08